Document resource
Introduction Emergency intracranial stenting in pediatric patients is a rare but potentially life-saving intervention in cases of severe neurovascular compromise unresponsive to medical treatment. While its use is well established in adults, pediatric data remain limited, particularly concerning safety, efficacy, and antiplatelet management in acute settings.Aim of Study This study presents a case series of six pediatric patients undergoing emergency intracranial stenting and proposes a practical, weight-based antiplatelet protocol to guide clinical management.Method We retrospectively reviewed six pediatric patients (ages 6–13) treated with emergency intracranial stenting at our institution between 2021 and 2024. Three patients received venous sinus stents for refractory pseudotumor cerebri. The remaining three underwent arterial stenting due to acute arterial dissection or focal arteriopathy with neurological deterioration despite maximal medical therapy and/or mechanical thrombectomy failure. All procedures were performed under general anesthesia by an experienced neurointerventional team. Pre-procedural imaging included MRI/MRV or CT/CTA. Antiplatelet therapy was tailored according to bleeding risk and imaging findings. Follow-up was conducted with an overall range of 3–36 months.Abstract A330 Figure 1Results All six patients survived with good clinical outcomes. No major thrombotic or hemorrhagic complications occurred during the follow-up period.Abstract A330 Figure 2Conclusion Emergency intracranial stenting in carefully selected pediatric patients is feasible and may be life-saving. Based on our experience, a weight-based antiplatelet protocol appears safe and effective. Multicenter studies are needed to confirm these findings and support the development of standardized pediatric guidelines.Conflict of Interest No